Biologics and biosimilars : balancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009

LDR 02148cam a2200397 a 4500
001 008020955
003 MiAaHDL
005 20110215000000.0
006 m d
007 cr bn ---auaua
008 100601s2010 dcua b f000 0 eng c
010 ⊔ ⊔ ‡a 2010478486
020 ⊔ ⊔ ‡a0160858143
020 ⊔ ⊔ ‡a9780160858147
035 ⊔ ⊔ ‡asdr-pur2671642
035 ⊔ ⊔ ‡asdr-miu.990080209550106381
035 ⊔ ⊔ ‡a(OCoLC)635495590
037 ⊔ ⊔ ‡a552-070-41031-7 ‡bGPO
040 ⊔ ⊔ ‡aGPO ‡cGPO ‡dDLC ‡dGPO ‡dMvI
042 ⊔ ⊔ ‡apcc
043 ⊔ ⊔ ‡an-us---
049 ⊔ ⊔ ‡ahsse,govd
050 1 4 ‡aKF27 ‡b.J8568 2009e
074 ⊔ ⊔ ‡a1020-A
086 0 ⊔ ‡aY 4.J 89/1:111-73
088 ⊔ ⊔ ‡aSerial no. 111-73 (United States. Congress. House. Committee on the Judiciary)
099 ⊔ 9 ‡aInternet
110 1 ⊔ ‡aUnited States. ‡bCongress. ‡bHouse. ‡bCommittee on the Judiciary. ‡bSubcommittee on Courts and Competition Policy.
245 1 0 ‡aBiologics and biosimilars : ‡bbalancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009.
260 ⊔ ⊔ ‡aWashington : ‡bU.S. G.P.O. : ‡bFor sale by the Supt. of Docs., U.S. G.P.O., ‡c2010.
300 ⊔ ⊔ ‡aiv, 252 p. : ‡bill. ; ‡c24 cm.
500 ⊔ ⊔ ‡a"Serial no. 111-73."
500 ⊔ ⊔ ‡aShipping list no.: 2010-0263-P.
504 ⊔ ⊔ ‡aIncludes bibliographical references.
538 ⊔ ⊔ ‡aMode of access: Internet.
650 ⊔ 0 ‡aBiologicals ‡xGovernment policy ‡zUnited States.
650 ⊔ 0 ‡aPharmaceutical biotechnology ‡zUnited States ‡vPatents.
650 ⊔ 0 ‡aPharmaceutical biotechnology ‡xGovernment policy ‡zUnited States.
650 ⊔ 0 ‡aDrug development ‡xGovernment policy ‡zUnited States.
776 0 8 ‡iMicrofiche: ‡aUnited States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy. ‡tBiologics and biosimilars : ‡bbalancing incentives for innovation ‡hiv, 252 p. ‡w(OCoLC)663903300
776 0 8 ‡iOnline version: ‡aUnited States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy. ‡tBiologics and biosimilars : ‡bbalancing incentives for innovation ‡hiv, 252 p. ‡w(OCoLC)635577699
CID ⊔ ⊔ ‡a008020955
DAT 0 ⊔ ‡a20101018162819.0 ‡b20110215000000.0
DAT 1 ⊔ ‡a20120815064345.0 ‡b2023-07-21T18:17:27Z
CAT ⊔ ⊔ ‡aSDR-PUR ‡dUNKNOWN ‡lloader.pl-001-001
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-pur2671642 ‡apur1 ‡bSDR ‡cPUR ‡ppur1.32754081279790 ‡sPUR ‡12671642
974 ⊔ ⊔ ‡bPUR ‡cPUR ‡d20230721 ‡sgoogle ‡upur1.32754081279790 ‡y2010 ‡rpd ‡qbib ‡tUS fed doc
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20231129 ‡sgoogle ‡umdp.39015090381693 ‡y2010 ‡rpd ‡qbib ‡tUS fed doc